BIROn - Birkbeck Institutional Research Online

    Institutions, industry and barriers in the biotechnology sector: developed-developing country perspectives

    Bagchi-Sen, S. and Lawton Smith, Helen (2008) Institutions, industry and barriers in the biotechnology sector: developed-developing country perspectives. Regional Studies 42 (7), pp. 961-975. ISSN 0034-3404.

    Full text not available from this repository.

    Abstract

    To be competitive Indian pharmaceutical and biotechnology companies pursue both imitative and innovation-based strategies. Some undertake contractual clinical research from multinationals now that product patents have replaced process patenting. The barriers for innovation are the lack of funds and regulations. Government funding bodies have to reconcile the goals: science for society versus science for profit. The regulatory process (e.g. time taken for drug approvals) is in need of change. In recent years the industry has become more regionalized – states are proactive in promoting bioscience complexes through parks and institutes (e.g. Bangalore and Hyderabad). This has implications for clustered economic development.

    Metadata

    Item Type: Article
    School: Birkbeck Faculties and Schools > Faculty of Business and Law > Birkbeck Business School
    Research Centres and Institutes: Innovation Management Research, Birkbeck Centre for
    Depositing User: Sarah Hall
    Date Deposited: 29 Sep 2014 15:01
    Last Modified: 02 Aug 2023 17:12
    URI: https://eprints.bbk.ac.uk/id/eprint/10621

    Statistics

    Activity Overview
    6 month trend
    0Downloads
    6 month trend
    277Hits

    Additional statistics are available via IRStats2.

    Archive Staff Only (login required)

    Edit/View Item Edit/View Item